Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus.
about
Thioridazine induces major changes in global gene expression and cell wall composition in methicillin-resistant Staphylococcus aureus USA300Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potentialLysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat modelPenicillin-binding proteins and beta-lactam resistanceIdentification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureusTranscriptome analysis of responses to rhodomyrtone in methicillin-resistant Staphylococcus aureusThe nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesisCell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges.Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infectionsSpecificity of L,D-transpeptidases from gram-positive bacteria producing different peptidoglycan chemotypes.Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments.Anchor structure of staphylococcal surface proteins. III. Role of the FemA, FemB, and FemX factors in anchoring surface proteins to the bacterial cell wall.Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus.Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesinsIncreased overall antibiotic susceptibility in Staphylococcus aureus femAB null mutants.Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the Staphylococcal peptidoglycan interpeptide bridge.Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.glmM operon and methicillin-resistant glmM suppressor mutants in Staphylococcus aureus.A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolatesSelf-protection against cell wall hydrolysis in Streptococcus milleri NMSCC 061 and analysis of the millericin B operonRecombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumoniaHost-guest chemistry of the peptidoglycanTeichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus.In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.Staphylococcus aureus methicillin-resistance factor fmtA is regulated by the global regulator SarA.Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.Specificities of FemA and FemB for different glycine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pentaglycine side chain formationAslfm, the D-aspartate ligase responsible for the addition of D-aspartic acid onto the peptidoglycan precursor of Enterococcus faecium.Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.Staphylococcus aureus mutants with increased lysostaphin resistance.Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation.Vancomycin resistance: occurrence, mechanisms and strategies to combat it.Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formationLysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo.
P2860
Q21133515-23424845-495F-444F-9B19-30FA8F221202Q21136165-CCA52DA9-4D5B-4570-933D-676A856043B0Q24682172-26B1E3F9-B993-429F-AD37-7D7EFBD8EC3AQ28267300-4DF55E1A-36E0-4624-BF33-2B8CFEAAE9D1Q28480400-298D8F39-4239-4BC3-9BEF-87998A4A8674Q28484093-7C8EB401-027A-49DB-A692-62E17ABA5A21Q28484891-D2AC8B12-C4F0-4521-9AC3-92EE75B9EFBDQ30160087-70CC5C6F-4F36-4882-9CAD-EE83C5C6EE66Q30872027-89114D8D-3863-4BA7-952E-338F94881563Q31101895-431B34F0-975F-4B03-A333-882C07745C9FQ31990101-6220AA1A-A9DB-41DA-B935-B1C3180D214CQ31993427-887D64EE-B020-4226-8B10-CC270BBA869FQ33296902-D3FB449E-9C7D-4F0D-9241-0A7337B3CE24Q33538951-03BC3931-EA20-4164-BC96-F42494CA36F2Q33664443-DF3DC34C-ACBB-41BE-ADA1-DFB3BB8BE703Q33690984-2CE3D675-6507-40C0-97EA-9C324517F80BQ33692894-2F00DEA0-53AE-41B4-B640-36D88A34F2D4Q33775374-4CDEE5BA-87F4-4281-85D4-F87DF39222D9Q33790539-64D4D9C9-C7DE-44F1-8BE8-0EBBA1661B8BQ33938244-7E6C696D-415E-4922-96B1-87917FE6F51AQ33975995-EE94E1E9-3170-4BDA-A9E4-82E8FD8DB7F8Q33981239-508F67DC-688C-45ED-953F-3C90C16A10C5Q33990176-65A471AF-377D-4A40-96BA-04C03C90745BQ34012319-0E35173B-B870-4BDF-9733-ADB847C34528Q34013593-5FEDC213-DB1E-4C6D-9BA2-A557F1A0C1A0Q34279327-C7D3D4C1-ADEC-44C0-A58B-1D4BCC1F09A9Q34330366-78C4E0E1-5FC5-4514-AA69-F55915BBB3E9Q34406036-FE2E156C-539A-4D1D-932C-8F0FE5AB57F3Q34448260-24825A78-CF70-46DD-8C7B-A0AA45108866Q34448711-6C5FE6B9-E462-4386-9DB9-13F7D464CCCEQ34498657-6E88BF3D-AC23-4AAF-A064-79A5DEEEE2D9Q34514398-DE3F062F-8035-4872-A9E9-5CCEC539FE89Q34779009-BC216F7B-7A6B-4A60-98A5-64252C0AD0B0Q34823746-69BB75AA-2990-4220-A77E-E2A7CA76ABFFQ35075303-BE32701C-1E4E-4FD0-BF07-597CE3CE3728Q35139449-1016DE5D-0288-4AAB-84AE-B506A0B9F309Q35143886-CABB2AA4-AB80-41E3-A7BF-6D5283393D6DQ35376362-97F37862-ED9B-46B4-8D94-F214C8C5E9F1Q35604130-CE034984-F703-401A-9FE3-F8EFA0E3238EQ35635997-F12B7981-B02F-486E-A792-9537433C732E
P2860
Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Cell wall monoglycine cross-br ...... sistant Staphylococcus aureus.
@ast
Cell wall monoglycine cross-br ...... sistant Staphylococcus aureus.
@en
type
label
Cell wall monoglycine cross-br ...... sistant Staphylococcus aureus.
@ast
Cell wall monoglycine cross-br ...... sistant Staphylococcus aureus.
@en
prefLabel
Cell wall monoglycine cross-br ...... sistant Staphylococcus aureus.
@ast
Cell wall monoglycine cross-br ...... sistant Staphylococcus aureus.
@en
P2093
P2860
P1476
Cell wall monoglycine cross-br ...... sistant Staphylococcus aureus.
@en
P2093
Berger-Bächi B
Labischinski H
Strandén AM
P2860
P356
10.1128/JB.179.1.9-16.1997
P407
P577
1997-01-01T00:00:00Z